GPs' implicit prioritization through clinical choices – evidence from three national health services

Julie Riise, Arne Risa Hole, Dorte Gyrd-Hansen, Diane Skatun

Research output: Contribution to journalArticle

4 Citations (Scopus)
4 Downloads (Pure)

Abstract

We present results from an extensive discrete choice experiment, which was conducted in three countries (Norway, Scotland, and England) with the aim of disclosing stated prescription behaviour in different decision making contexts and across different cost containment cultures. We show that GPs in all countries respond to information about societal costs, benefits and effectiveness, and that they make trade-offs between them. The UK GPs have higher willingness to accept costs when they can prescribe medicines that are cheaper or more preferred by the patient, while Norwegian GPs tend to have higher willingness to accept costs for attributes regarding effectiveness or the doctors' experience. In general, there is a substantial amount of heterogeneity also within each country. We discuss the results from the DCE in the light of the GPs' two conflicting agency roles and what we know about the incentive structures and cultures in the different countries.
Original languageEnglish
Pages (from-to)169-183
Number of pages15
JournalJournal of Health Economics
Volume49
Early online date7 Jul 2016
DOIs
Publication statusPublished - Sep 2016

Fingerprint

National Health Programs
Cost-Benefit Analysis
Costs and Cost Analysis
Cost Control
Scotland
Norway
England
Prescriptions
Motivation
Decision Making

Keywords

  • prioritization
  • discrete choice experiments
  • prescription behaviour
  • GPs
  • cost containment

Cite this

GPs' implicit prioritization through clinical choices – evidence from three national health services. / Riise, Julie; Hole, Arne Risa; Gyrd-Hansen, Dorte ; Skatun, Diane.

In: Journal of Health Economics, Vol. 49, 09.2016, p. 169-183.

Research output: Contribution to journalArticle

@article{626d82c4e8bf416eb63634b9a81819ec,
title = "GPs' implicit prioritization through clinical choices – evidence from three national health services",
abstract = "We present results from an extensive discrete choice experiment, which was conducted in three countries (Norway, Scotland, and England) with the aim of disclosing stated prescription behaviour in different decision making contexts and across different cost containment cultures. We show that GPs in all countries respond to information about societal costs, benefits and effectiveness, and that they make trade-offs between them. The UK GPs have higher willingness to accept costs when they can prescribe medicines that are cheaper or more preferred by the patient, while Norwegian GPs tend to have higher willingness to accept costs for attributes regarding effectiveness or the doctors' experience. In general, there is a substantial amount of heterogeneity also within each country. We discuss the results from the DCE in the light of the GPs' two conflicting agency roles and what we know about the incentive structures and cultures in the different countries.",
keywords = "prioritization, discrete choice experiments, prescription behaviour, GPs, cost containment",
author = "Julie Riise and Hole, {Arne Risa} and Dorte Gyrd-Hansen and Diane Skatun",
note = "Acknowledgments The authors are grateful for valuable comments and inputs from participants at a series of seminars and conferences as well as to our three anonymous referees.",
year = "2016",
month = "9",
doi = "10.1016/j.jhealeco.2016.07.001",
language = "English",
volume = "49",
pages = "169--183",
journal = "Journal of Health Economics",
issn = "0167-6296",
publisher = "Elsevier",

}

TY - JOUR

T1 - GPs' implicit prioritization through clinical choices – evidence from three national health services

AU - Riise, Julie

AU - Hole, Arne Risa

AU - Gyrd-Hansen, Dorte

AU - Skatun, Diane

N1 - Acknowledgments The authors are grateful for valuable comments and inputs from participants at a series of seminars and conferences as well as to our three anonymous referees.

PY - 2016/9

Y1 - 2016/9

N2 - We present results from an extensive discrete choice experiment, which was conducted in three countries (Norway, Scotland, and England) with the aim of disclosing stated prescription behaviour in different decision making contexts and across different cost containment cultures. We show that GPs in all countries respond to information about societal costs, benefits and effectiveness, and that they make trade-offs between them. The UK GPs have higher willingness to accept costs when they can prescribe medicines that are cheaper or more preferred by the patient, while Norwegian GPs tend to have higher willingness to accept costs for attributes regarding effectiveness or the doctors' experience. In general, there is a substantial amount of heterogeneity also within each country. We discuss the results from the DCE in the light of the GPs' two conflicting agency roles and what we know about the incentive structures and cultures in the different countries.

AB - We present results from an extensive discrete choice experiment, which was conducted in three countries (Norway, Scotland, and England) with the aim of disclosing stated prescription behaviour in different decision making contexts and across different cost containment cultures. We show that GPs in all countries respond to information about societal costs, benefits and effectiveness, and that they make trade-offs between them. The UK GPs have higher willingness to accept costs when they can prescribe medicines that are cheaper or more preferred by the patient, while Norwegian GPs tend to have higher willingness to accept costs for attributes regarding effectiveness or the doctors' experience. In general, there is a substantial amount of heterogeneity also within each country. We discuss the results from the DCE in the light of the GPs' two conflicting agency roles and what we know about the incentive structures and cultures in the different countries.

KW - prioritization

KW - discrete choice experiments

KW - prescription behaviour

KW - GPs

KW - cost containment

U2 - 10.1016/j.jhealeco.2016.07.001

DO - 10.1016/j.jhealeco.2016.07.001

M3 - Article

VL - 49

SP - 169

EP - 183

JO - Journal of Health Economics

JF - Journal of Health Economics

SN - 0167-6296

ER -